Colby’s practice is focused on patent infringement and trade secret matters.

Colby has consistently secured the best possible outcomes for his clients—from rapid case dismissals to highly favorable jury verdicts, arbitration awards, and statements of decision in bench trial matters.

Colby has patent litigation experience before numerous district courts throughout the United States, and the Court of Appeals for the Federal Circuit. He has handled multiple patent infringement actions in each of the most common jurisdictions, including Delaware, Texas, California, and New York. Colby also has experience before the major arbitral institutions in the United States, such as the American Arbitration Association (AAA) and Judicial Arbitration and Mediation Services, Inc. (JAMS). Leveraging his background in biochemistry, Colby has assisted in cases on behalf of some of the world’s largest life sciences and pharmaceuticals companies. He also has substantial experience litigating patents related to laboratory equipment, telecommunications, and more.

Expertise

Industries

Qualifications

Admissions

Attorney at Law, California, U.S., 2015

Attorney at Law, Tennessee, U.S., 2020

Attorney at Law, District of Columbia, U.S., 2022

Patent Attorney, United States Patent and Trademark Office, U.S., 2023

United States District Court for the Central District of California, U.S., 2015

United States District Court for the Eastern District of Texas, U.S., 2021

United States District Court for the Western District of Texas, U.S., 2023

United States Court of Appeals for the Federal Circuit, U.S., 2021
 

Academic

JD, Intellectual Property Law,University of California, Los Angeles (UCLA), 2015

BA, Cellular & Molecular Biology, Vanderbilt University, 2010

MA, Secondary Education, Marian University, 2012

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.